EP3938368
COMPOUND FORM HAVING ENHANCED BIOAVAILABILITY AND FORMULATIONS THEREOF
:
EP einkaleyfi: Þýðing ekki lögð inn:
9.3.2020:
7.6.2023:
20717027.5
:
8.3.2040
:
COMPOUND FORM HAVING ENHANCED BIOAVAILABILITY AND FORMULATIONS THEREOF
9.3.2020
7.6.2023
:
PTC Therapeutics, Inc.:
100 Corporate Court,, South Plainfield, NJ 07080, US
:
UDDIN, Akm, Nasir:
Somerset, NJ 08873, US
:
DALI, Mandar, Vasant:
Bridgewater, NY 08807, US
:
VAZE, Onkar, Shripad:
Fords, NJ 08863, US
:
201962816402 P:
11.3.2019:
US
:
US2020021648:
9.3.2020
:
C07D 487/04